July 21st 2025, 5:00pm
IV infiltration and extravasation remind this cancer patient of the constant challenges of speaking up and advocating for their own care.
July 21st 2025, 4:00pm
Billions of dollars of cancer meds go to waste each year while many patients struggle to afford treatment; donating surplus medicine helps bridge this gap.
July 21st 2025, 1:00pm
Dr. Ari Hakimi highlighted how tumor profiling and molecular markers are expanding access to precision-based trials for kidney cancer.
July 20th 2025, 6:00pm
Welireg improved quality-adjusted survival time versus Afinitor in advanced renal cell carcinoma, extending progression-free survival and reducing side effects.
July 20th 2025, 2:00pm
Researchers are building on the success of CAR T therapy in blood cancers to explore its use in clear cell renal cell carcinoma, a type of kidney cancer.
July 19th 2025, 6:00pm
Early data suggest personalized neoantigen vaccines activate the immune system and sustain tumor control in some patients with kidney cancer.
July 19th 2025, 2:00pm
Patients with skin cancer who were fed a high-fiber diet showed better response rates to treatment and longer event-free survival, according to data from the DIET trial.
July 18th 2025, 9:00pm
After attending several cancer support groups, I reflect on what makes them helpful, inclusive and healing — and invite others to share their insights too.
July 18th 2025, 8:00pm
Personalized cancer vaccines may potentially represent a step forward in guiding the immune system to more precisely target kidney cancer.
July 18th 2025, 7:00pm
Quality-of-life in lung cancer varies, with certain treatments leading to sleep-related issues, pain, and emotional changes depending on disease stage.
Understanding Your Diagnosis of Bile Duct Cancer
Understanding Your Stage 2 Uterine (Endometrial) Cancer
Top Blood Cancer Stories from October: Key Updates for Patients
Expert Explains Need for Better Outcomes in Resectable Lung Cancer